FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

28943111000001104: Concerta XL 54mg tablets (Janssen-Cilag Ltd) 30 tablet (product)


Status: current, Not sufficiently defined by necessary conditions definition status. Date: 29-Apr 2015. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
91117501000001112 Concerta XL 54mg tablets (Janssen-Cilag Ltd) 30 tablet (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
91117601000001111 Concerta XL 54mg tablets (Janssen-Cilag Ltd) 30 tablet en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Concerta XL 54mg tablets (Janssen-Cilag Ltd) 30 tablet Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Concerta XL 54mg tablets (Janssen-Cilag Ltd) 30 tablet Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category Schedule 2 (CD) true Inferred relationship Existential restriction modifier
Concerta XL 54mg tablets (Janssen-Cilag Ltd) 30 tablet Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Concerta XL 54mg tablets (Janssen-Cilag Ltd) 30 tablet Is a Methylphenidate 54mg modified-release tablets 30 tablet true Inferred relationship Existential restriction modifier
Concerta XL 54mg tablets (Janssen-Cilag Ltd) 30 tablet Has AMP Concerta XL 54mg tablets (Janssen-Cilag Ltd) true Inferred relationship Existential restriction modifier
Concerta XL 54mg tablets (Janssen-Cilag Ltd) 30 tablet Has excipient Propylene glycol false Inferred relationship Existential restriction modifier
Concerta XL 54mg tablets (Janssen-Cilag Ltd) 30 tablet Has excipient Lactose false Inferred relationship Existential restriction modifier
Concerta XL 54mg tablets (Janssen-Cilag Ltd) 30 tablet Has excipient Butylated hydroxytoluene false Inferred relationship Existential restriction modifier
Concerta XL 54mg tablets (Janssen-Cilag Ltd) 30 tablet VMP prescribing status (attribute) VMP valid as a prescribable product false Inferred relationship Existential restriction modifier
Concerta XL 54mg tablets (Janssen-Cilag Ltd) 30 tablet VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Concerta XL 54mg tablets (Janssen-Cilag Ltd) 30 tablet Has specific active ingredient Methylphenidate hydrochloride true Inferred relationship Existential restriction modifier
Concerta XL 54mg tablets (Janssen-Cilag Ltd) 30 tablet Has dispensed dose form Modified-release oral tablet true Inferred relationship Existential restriction modifier
Concerta XL 54mg tablets (Janssen-Cilag Ltd) 30 tablet Legal category Prescription only medicine - legal category (qualifier value) true Inferred relationship Existential restriction modifier
Concerta XL 54mg tablets (Janssen-Cilag Ltd) 30 tablet Discontinued indicator Never discontinued true Inferred relationship Existential restriction modifier
Concerta XL 54mg tablets (Janssen-Cilag Ltd) 30 tablet Is a Actual medicinal product pack true Inferred relationship Existential restriction modifier
Concerta XL 54mg tablets (Janssen-Cilag Ltd) 30 tablet VMP prescribing status (attribute) VMP not recommended to prescribe - brands not bioequivalent false Inferred relationship Existential restriction modifier
Concerta XL 54mg tablets (Janssen-Cilag Ltd) 30 tablet VMP prescribing status (attribute) Caution - AMP level prescribing advised true Inferred relationship Existential restriction modifier

Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start